UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,748,000 | -64.1% | 594,800 | -58.8% | 0.02% | -57.1% |
| Q4 2021 | $29,925,000 | -71.6% | 1,442,842 | -56.1% | 0.06% | -72.1% |
| Q3 2021 | $105,302,000 | +2.4% | 3,289,661 | -1.5% | 0.20% | +4.7% |
| Q2 2021 | $102,847,000 | -11.4% | 3,339,176 | -3.0% | 0.19% | -14.7% |
| Q1 2021 | $116,034,000 | -16.7% | 3,444,176 | -10.7% | 0.22% | -21.1% |
| Q4 2020 | $139,303,000 | +12.0% | 3,855,615 | +14.1% | 0.28% | -2.4% |
| Q3 2020 | $124,419,000 | -10.9% | 3,378,207 | +9.0% | 0.29% | -15.6% |
| Q2 2020 | $139,700,000 | +0.5% | 3,100,307 | +5.8% | 0.35% | -15.4% |
| Q1 2020 | $139,070,000 | -35.6% | 2,930,878 | -2.7% | 0.41% | -15.0% |
| Q4 2019 | $215,800,000 | +82.1% | 3,011,446 | +0.0% | 0.48% | +65.3% |
| Q3 2019 | $118,507,000 | -13.5% | 3,010,846 | +71.8% | 0.29% | -12.3% |
| Q2 2019 | $136,988,000 | +80.5% | 1,752,893 | +37.8% | 0.33% | +76.6% |
| Q1 2019 | $75,888,000 | +68.2% | 1,272,228 | -18.7% | 0.19% | +52.8% |
| Q4 2018 | $45,121,000 | -20.8% | 1,565,600 | 0.0% | 0.12% | -7.5% |
| Q3 2018 | $56,972,000 | +38.1% | 1,565,600 | +43.5% | 0.13% | +9.9% |
| Q2 2018 | $41,250,000 | +91.2% | 1,091,280 | +18.9% | 0.12% | +92.1% |
| Q1 2018 | $21,573,000 | – | 917,999 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |